Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000921895-25-000109·Inmune Bio, Inc.
Schedule 13G ownership disclosure
Inmune Bio Inc
Common Stock, par value $0.001 per share · CUSIP: 45782T105
Event date: 2025-01-15
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Praetorian PR LLC
Shares: 1,103,210.00 · Class: 4.9%
- Praetorian Capital Fund LLC
Shares: 1,103,210.00 · Class: 4.9%
- Praetorian Capital Management LLC
Shares: 1,103,210.00 · Class: 4.9%
- Mongolia (Barbados) Corp.
Shares: 135,753.00 · Class: 0.6%
- Mongolia Growth Group Ltd.
Shares: 135,753.00 · Class: 0.6%
- Kupperman Harris
Shares: 1,238,963.00 · Class: 5.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-25-000109
- Form type
- SCHEDULE 13G
- Filer
- Inmune Bio, Inc.
- CIK
- CIK 1711754
- Filed
- Jan 15, 2025
- Reporting period
- Jan 15, 2025
- Description
- Schedule 13G beneficial ownership